Bacterial contamination and skin microbiome imbalances lead to product spoilage and inflammatory conditions, which are mitigated by engineering stable phage-derived protein delivery systems. These formulations utilize specific polymer and polyol matrices to maintain enzymatic activity in anhydrous and oil-based environments.